IPGDx Blog

Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer

In my previous blog post “Phase Angle Is A Prognostic Factor” I wrote about how/why Phase Angle is a reliable and objective prognostic indicator.  Here I point you towards a research done on fifty-eight stage IV pancreatic cancer patients treated at Cancer Treatment Centers of American at Midwestern Regional Medical Center (Zion, IL, USA) between January 2000 and July 2003.

Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer

Please review the research details – but here is the summary from the research “In summary, our present study has demonstrated the prognostic significance of the phase angle in advanced pancreatic cancer. To the best of our knowledge this is the first study to evaluate phase angle for its prognostic importance in advanced pancreatic cancer.”

It makes me very happy – how our medical device PrognostiCheck(R) will help patients, physicians and their families across the world.

Tags: pancreatic cancer, Prognosis

Phase Angle is a Prognostic Factor

Phase angle determined by PrognostiCheck(R) detects changes in tissue electrical properties and is a reliable and objective prognostic indicator in several chronic conditions—such as HIV, liver cirrhosis, chronic obstructive pulmonary disease, breast cancer, colorectal cancer, pancreatic cancer and lung cancer—and in patients receiving dialysis.

Please refer to the below supporting documents

Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer

Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis

Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment

A good reading is a  similar blog post over at idoctor.ro .

Please leave a comment if you would like to have more information.

PrognostiCheck(R): Diagnostic tool to measure patient prognosis

Early detection and correct prognosis of serious illness is critical – and are paramount to improving patient survival rates. PrognostiCheck(R) is a scoring system based upon an electrical measurement of cellular architecture of a patient. The study utilizes an electrical illustration of the cell-wall membrane of a phospho-lipid bi-layer cell who’s ability to act as a capacitor and hold the electrical signal is indicative of the health of the patient.

It detects the presence and severity of disease, the effectiveness of treatment, the burden of the illness on the individual patient and whether they are recovering. We invite you to explore our innovate product and look forward for your comments.

Tags: Measure Prognosis

PrognostiCheck® Illustrates The Presence Of Disease

PrognostiCheck® measures prognosis sooner. Check out following visual to understand PrognostiCheck® in 30 seconds.

Tags: Burden of Disease, course of disease, Disease complications, Disease Indicator, Disease Management, Disease Outcome, Disease Progression, Disease severity, Effectiveness of Treatment, measurement, Present on admission, Prognosis, Trajectory of disease, Treatment and Prognosis

Measure Prognosis Sooner

Dealing with breast cancer, prostate cancer or any type of serious illness is hard enough. Why waste precious time to see how the disease is progressing.  Fortunately, now there’s a simple, reliable and objective test that can help you and your doctor learn your prognosis sooner.

PrognostiCheck ® is a simple non-invasive medical device which measures the health of your cells – were disease starts. Physical symptoms appear later.

Your doctor  can use PrognostiCheck ^® along with your current treatment to make better, informed and objective decisions sooner. To learn more about PrognostiCheck ^® click  here.

Tags: Conditions and Diseases, Prognosis, PrognostiCheck ®., Prostate cancer